Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lukas

Showing results (71-80 of 416) with videos related to

Pageof 42
Sort By:
Brain Research|July 1, 1986
Allosteric modification of alpha-bungarotoxin binding by the 'calcium channel antagonist' verapamilH N Siegel, R J Lukas
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypesC L Gentry, R J Lukas
Journal of Neurochemistry|December 1, 1979
Agonist-induced affinity alterations of a central nervous system alpha-bungarotoxin receptorR J Lukas, E L Bennett
The Journal of Biological Chemistry|June 25, 1980
Chemical modification and reactivity of sulfhydryls and disulfides of rat brain nicotinic-like acetylcholine receptorsR J Lukas, E L Bennett
Oncology Reports|May 20, 2011
A common path to tumor growthJ Bartek, J Lukas, M Strauss
Methods in Molecular Biology (Clifton, N.J.)|December 7, 2011
Isolation and culture of astrocytes from the retina and optic nerveThomas J Lukas, Ai Ling Wang
Molecular Pharmacology|March 1, 1980
Interaction of nicotinic receptor affinity reagents with central nervous system alpha-bungarotoxin-binding entitiesR J Lukas, E L Bennett
Scientific Reports|November 8, 2022
The vaccination rift effect provides evidence that source vaccination status determines the rejection of calls to get vaccinatedJ Lukas Thürmer, Sean M McCrea
The American Journal of Pathology|January 7, 2000
p53 mutations and expression in breast carcinoma in situJ Lukas, N Niu, M F Press
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposureR Reitstetter, R J Lukas, R Gruener
Pageof 42

Showing results (71-80 of 416) with videos related to

Sort By:
Pageof 42
Brain Research|July 1, 1986
Allosteric modification of alpha-bungarotoxin binding by the 'calcium channel antagonist' verapamilH N Siegel, R J Lukas
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypesC L Gentry, R J Lukas
Journal of Neurochemistry|December 1, 1979
Agonist-induced affinity alterations of a central nervous system alpha-bungarotoxin receptorR J Lukas, E L Bennett
The Journal of Biological Chemistry|June 25, 1980
Chemical modification and reactivity of sulfhydryls and disulfides of rat brain nicotinic-like acetylcholine receptorsR J Lukas, E L Bennett
Oncology Reports|May 20, 2011
A common path to tumor growthJ Bartek, J Lukas, M Strauss
Methods in Molecular Biology (Clifton, N.J.)|December 7, 2011
Isolation and culture of astrocytes from the retina and optic nerveThomas J Lukas, Ai Ling Wang
Molecular Pharmacology|March 1, 1980
Interaction of nicotinic receptor affinity reagents with central nervous system alpha-bungarotoxin-binding entitiesR J Lukas, E L Bennett
Scientific Reports|November 8, 2022
The vaccination rift effect provides evidence that source vaccination status determines the rejection of calls to get vaccinatedJ Lukas Thürmer, Sean M McCrea
The American Journal of Pathology|January 7, 2000
p53 mutations and expression in breast carcinoma in situJ Lukas, N Niu, M F Press
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposureR Reitstetter, R J Lukas, R Gruener
Pageof 42